The emerging class of GLP-1 receptor agonist and GIP co-agonist medications, including tirzepatide, semaglutide, and the newly introduced retatrutide, offer promising improvements in the management . https://bpc-157642189.blogunteer.com/42275682/tirzepatide-the-comparative-examination